Shoji Takakura

Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats

Yuka Hayashizaki-Someya, Eiji Kurosaki, Toshiyuki Takasu et al. · European Journal of Pharmacology · 2015 · 108 citations

Inflammation, Metabolic Syndrome, Sglt2 Inhibitor +15

Effect of ipragliflozin, an SGLT2 inhibitor, on progression of diabetic microvascular complications in spontaneously diabetic Torii fatty rats

Shoji Takakura, Tohru Toyoshi, Yuka Hayashizaki et al. · Life Sciences · 2016 · 66 citations

Inflammation, Metabolic Syndrome, Diabetes Management +12

Implitapide, a Microsomal Triglyceride Transfer Protein Inhibitor, Reduces Progression of Atherosclerosis in Apolipoprotein E Knockout Mice Fed a Western-Type Diet: Involvement of the Inhibition of Postprandial Triglyceride Elevation

Koji Ueshima, Hitomi Akihisa-Umeno, Akira Nagayoshi et al. · Biological and Pharmaceutical Bulletin · 2005 · 63 citations · Full text

Apoe Ko, Reduces Progression, Metabolic Syndrome +16

The structure of human recombinant aldose reductase complexed with the potent inhibitor zenarestat

Takayoshi Kinoshita, Hiroshi Miyake, Takashi Fujii et al. · Acta Crystallographica Section D Biological Crystallography · 2002 · 49 citations

Molecular Docking, Crystal Structure, Medicinal Chemistry +15

Characterization of a 2,4-Dinitrochlorobenzene-Induced Chronic Dermatitis Model in Rats

Yasutomo Fujii, Hiroaki Takeuchi, Shozo Sakuma et al. · Skin Pharmacology and Physiology · 2009 · 45 citations

Inflammation, Allergy, Autoimmune Disease +13